| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia
|
Berger, Mathilde
|
|
2019
|
110 |
C |
p. 49-52
|
artikel
|
| 2 |
ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children
|
Pearson, Andrew D.J.
|
|
2019
|
110 |
C |
p. 74-85
|
artikel
|
| 3 |
Adjuvant androgen deprivation therapy for poor-risk, androgen receptor–positive salivary duct carcinoma
|
van Boxtel, W.
|
|
2019
|
110 |
C |
p. 62-70
|
artikel
|
| 4 |
Avoidable cancers in the Nordic countries—the potential impact of increased physical activity on postmenopausal breast, colon and endometrial cancer
|
Andersson, Therese M-L.
|
|
2019
|
110 |
C |
p. 42-48
|
artikel
|
| 5 |
Cold agglutinin disease as a new immune-related adverse event associated with anti-PD-L1s and its treatment with rituximab
|
Dutertre, Martin
|
|
2019
|
110 |
C |
p. 21-23
|
artikel
|
| 6 |
Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors
|
Ferrari, Andrea
|
|
2019
|
110 |
C |
p. 120-126
|
artikel
|
| 7 |
Effects of adjuvant tamoxifen over three decades on breast cancer–free and distant recurrence–free interval among premenopausal women with oestrogen receptor–positive breast cancer randomised in the Swedish SBII:2pre trial
|
Ekholm, M.
|
|
2019
|
110 |
C |
p. 53-61
|
artikel
|
| 8 |
Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases
|
Rauschenberg, Ricarda
|
|
2019
|
110 |
C |
p. 11-20
|
artikel
|
| 9 |
Increased survival of non low-grade and deep-seated soft tissue sarcoma after surgical management in high-volume hospitals: a nationwide study from the Netherlands
|
Vos, Melissa
|
|
2019
|
110 |
C |
p. 98-106
|
artikel
|
| 10 |
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry
|
Bagnasco, Francesca
|
|
2019
|
110 |
C |
p. 86-97
|
artikel
|
| 11 |
Mitochondrial myopathy associated with anti-programmed cell death 1 therapy
|
Ibrahim, Tony
|
|
2019
|
110 |
C |
p. 71-73
|
artikel
|
| 12 |
Monitoring evidence on overall survival benefits of anticancer drugs approved by the European Medicines Agency between 2009 and 2015
|
Grössmann, N.
|
|
2019
|
110 |
C |
p. 1-7
|
artikel
|
| 13 |
Prurigo nodularis and pembrolizumab: A therapeutic challenge
|
Fattore, Davide
|
|
2019
|
110 |
C |
p. 8-10
|
artikel
|
| 14 |
Role of thoracic consolidation radiation in extensive stage small cell lung cancer: A systematic review and meta-analysis of randomised controlled trials
|
Rathod, Shrinivas
|
|
2019
|
110 |
C |
p. 110-119
|
artikel
|
| 15 |
Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast
|
Fattore, Davide
|
|
2019
|
110 |
C |
p. 107-109
|
artikel
|
| 16 |
Ten-year outcomes of survival and toxicity for a phase III randomised trial of concurrent chemoradiotherapy versus radiotherapy alone in stage II nasopharyngeal carcinoma
|
Li, Xiao-Yun
|
|
2019
|
110 |
C |
p. 24-31
|
artikel
|
| 17 |
Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial
|
Masi, Gianluca
|
|
2019
|
110 |
C |
p. 32-41
|
artikel
|
Tijdschrift beschrijving